Sinopharm Group Co.-Unsp ADRSHTDY
13F holders, Q1 2024 (March 31)3holders
$12.79avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Sinopharm Group Co.-Unsp ADR (SHTDY) in their 13F filings. The largest holders were Rhumbline Advisers ($8K), GAMMA Investing LLC ($4K) and PNC Financial Services Group, Inc. ($3K).
- Company
- Sinopharm Group Co.-Unsp ADR
- CUSIP
- 82937K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 3 holders
| Rhumbline Advisers | 0.00% | Reduce -12.5% | 638 | $8K |
| GAMMA Investing LLC | 0.00% | Add +138.9% | 313 | $4K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -80.6% | 236 | $3K |
"% of holder's portfolio" is SHTDY's weight in each manager's 13F, not the share of Sinopharm Group Co.-Unsp ADR the manager owns.